Latest Multi-drug-resistant tuberculosis Stories
New multi-year grant continues work to study pressing public health crisis TUCSON, Ariz., Sept.
Program to Enable Broader Access to Groundbreaking Tuberculosis Diagnostic SUNNYVALE, Calif., July 29, 2014 /PRNewswire/ -- With the recent completion of a record shipment of 774 GeneXpert
The World Health Organization (WHO) today, together with the European Respiratory Society (ERS), presented a new framework to eliminate tuberculosis (TB) in countries with low levels of the disease.
Promoting the Quality of Medicines (PQM) program helps attain WHO approval for treatment of drug resistant TB. Rockville, MD (PRWEB) June 10, 2014 The
Partnership Supports Newly Announced STAND Trial SEATTLE, April 23, 2014 /PRNewswire-USNewswire/ -- TB Alliance, an international non-profit drug development organization that develops
STAND trial will test the first regimen designed to significantly shorten and simplify the treatment of drug-sensitive and drug-resistant TB SEATTLE, April 23, 2014 /PRNewswire-USNewswire/
Presentation details three separate tuberculosis immunotherapies developed by Immunitor in collaboration with academic institutions and private companies in Mongolia, China, Thailand, Ukraine,
Global partnerships and significant medical research are a big part of this year’s World Tuberculosis Day. Celebrated each year on March 24, World TB Day is a marked as a time to bring attention to the threat of tuberculosis...
Thousands receive treatment prior to coming to the United States ATLANTA, March 20, 2014 /PRNewswire-USNewswire/ -- Updated CDC recommendations for overseas tuberculosis (TB) screening
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.